Sandoz is introducing Wyost (denosumab-bbdz) and Jubbonti (denosumab-bbdz, the first and only interchangeable FDA-approved denosumab biosimilars and are approved to treat all indications of Amgen ...

Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of its blockbuster ...

Sandoz is one of the largest off-patent pharmaceutical manufacturers in the world. It generates roughly 75% of sales from generic drugs with the remainder from biosimilars and has a significant ...

I got my first good night’s sleep in years. Incredibly, he advised me to take it only when needed. Since I had been waking up every single night to start with, where does that leave me?

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader with a question about the use of vitamin C for prevention of cataracts.

Sandoz Boss Warns There’s a Climate Cost of Obesity Wonder Drugs Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring.

Sandoz (SDZNY) announced a number of steps to resolve the US Generic Drug Antitrust Class Action Litigation. Following the previously announced settlements with the US Department of Justice in ...

Zolpidem, commonly known as Ambien, is used to treat insomnia, but it’s not without numerous side effects. How common is constipation?

“Railing against ‘Big Pharma’ while failing to support the market for generic and biosimilar medicines is missing the forest for the trees,” writes Sandoz CEO Richard Saynor.